Jura Bio

Developer of cell therapies for immunological disorders

placeBoston, Massachusetts, United States calendar_todayFounded 2017 groups7 employees language jura.bio

Registered entities

Innovation

3 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 67 times.

YearFilings
20191
20201
20211
20232
20241
20251
20261

Social engagement

Social engagement: 2.7K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

2 investors on record; lead investors include Fontus Capital.

Investor typeCountShare
Venture capital2100%
Coming soon